Long-term follow-up of CALGB (Alliance) 100001: Autologous followed by non-myeloablative allogeneic transplant for multiple myeloma

CALGB (Alliance) 100001 was a phase II study evaluating autologous stem cell transplant (ASCT) followed by non-myeloablative allogeneic stem cell transplant (alloSCT) in patients with multiple myeloma who had received no more than 18 months of prior therapy and had experienced no more than one prior...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Holstein, Sarah A., Suman, Vera J., Owzar, Kouros, Santo, Katelyn, Benson, Don M., Shea, Thomas C., Martin, Thomas, Silverman, Margarida, Isola, Luis, Vij, Ravi, Cheson, Bruce D., Linker, Charles, Anderson, Kenneth C., Richardson, Paul G., McCarthy, Philip L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7371544/
https://ncbi.nlm.nih.gov/pubmed/32325171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.03.028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados